TELA Bio Revenue and Competitors
Estimated Revenue & Valuation
- TELA Bio's estimated annual revenue is currently $40.2M per year.
- TELA Bio's estimated revenue per employee is $156,265
- TELA Bio's total funding is $105M.
Employee Data
- TELA Bio has 257 Employees.
- TELA Bio grew their employee count by 25% last year.
TELA Bio's People
Name | Title | Email/Phone |
---|---|---|
1 | Co-Founder, President And CEO | Reveal Email/Phone |
2 | Chief Operating Officer & Chief Financial Officer | Reveal Email/Phone |
3 | CTO | Reveal Email/Phone |
4 | COO & CFO | Reveal Email/Phone |
5 | Chief Accounting Officer and Controller | Reveal Email/Phone |
6 | VP Strategic Marketing | Reveal Email/Phone |
7 | VP- Regulatory and Quality | Reveal Email/Phone |
8 | VP at TELA Bio | Reveal Email/Phone |
9 | VP, Engagement & Education | Reveal Email/Phone |
10 | VP - Commercial Operations | Reveal Email/Phone |
TELA Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $73.5M | 293 | 12% | N/A | N/A |
#2 | $7M | 28 | -10% | N/A | N/A |
#3 | $37.9M | 151 | 13% | N/A | N/A |
#4 | $2.1M | 17 | -78% | $64.3M | N/A |
#5 | $9.3M | 37 | -10% | N/A | N/A |
#6 | $56.2M | 179 | 0% | N/A | N/A |
#7 | $38.9M | 155 | -1% | N/A | N/A |
#8 | $22.1M | 88 | 5% | N/A | N/A |
#9 | $22.1M | 88 | 9% | N/A | N/A |
#10 | $33.4M | 133 | 10% | N/A | N/A |
What Is TELA Bio?
TELA Bio, a surgical reconstruction company, was created out of the desire to do things differently. Our founders and seasoned leadership team bring their significant experience in medical technology to reinvigorate the soft tissue reconstruction market. Their goal is to build a customer-centric, low-bureaucracy, innovation-oriented organization. TELA Bio has the character of a start-up, with a refreshing approach to the market and a unique portfolio of products. Yet in our effort to create something new, we remain focused on high-quality, data-supported science, and thoughtful decision-making. Surgeons frequently have to work around the problematic features of products currently on the market. At TELA Bio, our starting point is the need for a product that gets it right, and this drives our innovation
keywords:N/A$105M
Total Funding
257
Number of Employees
$40.2M
Revenue (est)
25%
Employee Growth %
N/A
Valuation
N/A
Accelerator
TELA Bio News
TELA Bio, Inc, a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical...
TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize...
TELA Bio, Inc, a medical technology company, focuses on the design, development, and marketing of tissue reinforcement materials to address...
JUPITER, Fla. (PRWEB) September 03, 2021 Scheduled to broadcast 4Q/2021, Advancements with Ted Danson will focus on breakthroughs in soft tissue repair solutions. Check local listings for more information. Hearing from experts in the field, viewers will learn about TELA Bio® – a Pennsylvania-b ...
Regenerative surgical implants company Tela Bio has brought in more than $2 million in investments, according to a recent U.S. Securities and Exchange Commission filing. The Malvern, Pa.–based company had sought to raise a total $3 million, according to the SEC Form D filed Dec. 4. Get the ful ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1180M | 257 | 15% | N/A |
#2 | $53.5M | 266 | 20% | N/A |
#3 | $51.3M | 268 | 4% | N/A |
#4 | $81.1M | 273 | -1% | N/A |
#5 | $88.8M | 283 | 4% | $313.4M |